Royal Bank Of Canada Ice Cure Medical Ltd. Transaction History
Royal Bank Of Canada
- $528 Billion
- Q2 2025
A detailed history of Royal Bank Of Canada transactions in Ice Cure Medical Ltd. stock. As of the latest transaction made, Royal Bank Of Canada holds 500 shares of ICCM stock, worth $410. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500
Previous 500
-0.0%
Holding current value
$410
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ICCM
# of Institutions
19Shares Held
250KCall Options Held
0Put Options Held
0-
Ken Griffin Citadel Advisors LLC | Chicago, Il52.5KShares$43,0690.0% of portfolio
-
Geode Capital Management, LLC Boston, MA40.5KShares$33,1710.0% of portfolio
-
Two Sigma Securities, LLC New York, NY25.3KShares$20,7830.0% of portfolio
-
Gunderson Capital Management Inc.20KShares$16,4000.01% of portfolio
-
Lpl Financial LLC Fort Mill, SC18.9KShares$15,4770.0% of portfolio
About IceCure Medical Ltd.
- Ticker ICCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 36,835,600
- Market Cap $30.2M
- Description
- IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.